June 05, 2021
Rose
If the agency approves it, aducanumab would be the first new Alzheimer’s treatment since 2003. Patients are desperate for new options, but some scientists say there isn’t enough evidence it works.
from NYT > Health https://ift.tt/2SWS5su
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment